Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Pivot Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Target Concepts:
Gene/Protein
Disease
Symptom
Drug
Enzyme
Compound
Query: UMLS:C0038220 (
status epilepticus
)
7,272
document(s) hit in 31,850,051 MEDLINE articles (0.00 seconds)
Temporal lobe epilepsy (TLE) is a chronic neurological disease characterized by recurrent spontaneous seizures. MicroRNAs are dysregulated in various pathological conditions including epilepsy. Therefore, we hypothesized that the dysregulation of these microRNAs might also be associated with the pathogenesis of TLE. In this study, we found that a microRNA, hsa-miR-155-5p, was upregulated in patients with TLE post-surgery, and hence associated with clinical and pathological manifestations and seizure outcomes. We then used a rat model of experimental epilepsy induced by pilocarpine and revealed that the rat homologue was upregulated as well. Importantly, injection of an antagomiR of rno-miR-155-5p in vivo resulted in a reduction of the pathophysiological features associated with the
status epilepticus
, which was accompanied by decrease of apoptosis in the hippocampus. This effect was correlated with an increase in rat
Sestrin-3
expression, which was a gene known to counteract oxidative stress. This rescue was also observed after injection of a lentivirus carrying the small interfering RNA of rat
Sestrin-3
gene in the hippocampus. In addition, rno-miR-155-5p as well as rat
Sestrin-3
mRNA and protein expression were partly dependent on oxidative stress induced by H
2
O
2
in PC12 cells
.
Taken together, our data suggest that rno-miR-155-5p is a potent post-transcriptional regulator of rat
Sestrin-3
and it may be one of the molecular links between brain damage and increased risk for seizures during damage by oxidative stress.
...
PMID:Silencing rno-miR-155-5p in rat temporal lobe epilepsy model reduces pathophysiological features and cell apoptosis by activating Sestrin-3. 2919 71